Figure S6 from Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine
Sabrina Wang(Johns Hopkins Medicine), Jeffrey Rubens(Johns Hopkins University), Barbara S. Slusher(Johns Hopkins University), Allison R. Hanaford(Johns Hopkins Medicine), Brent A. Orr(St. Jude Children's Research Hospital), Antoinette Price(Johns Hopkins University), Eric H. Raabe(Johns Hopkins University), Jesse Alt(Johns Hopkins University), Sariah J. Allen(St. Jude Children's Research Hospital), Brad Poore(Johns Hopkins University), Harpreet Kaur, Charles G. Eberhart(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711